596 related articles for article (PubMed ID: 2521231)
1. Influence of recombinant IL-4, IFN-alpha, and IFN-gamma on the production of human IgE-binding factor (soluble CD23).
Delespesse G; Sarfati M; Peleman R
J Immunol; 1989 Jan; 142(1):134-8. PubMed ID: 2521231
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Fc epsilon R2/CD23 gene expression by cytokines and specific ligands (IgE and anti-Fc epsilon R2 monoclonal antibody). Variable regulation depending on the cell types.
Kawabe T; Takami M; Hosoda M; Maeda Y; Sato S; Mayumi M; Mikawa H; Arai K; Yodoi J
J Immunol; 1988 Aug; 141(4):1376-82. PubMed ID: 2969400
[TBL] [Abstract][Full Text] [Related]
3. IFN-alpha and IFN-gamma have different regulatory effects on IL-4-induced membrane expression of Fc epsilon RIIb and release of soluble Fc epsilon RIIb by human monocytes.
te Velde AA; Rousset F; Peronne C; De Vries JE; Figdor CG
J Immunol; 1990 Apr; 144(8):3052-9. PubMed ID: 2139077
[TBL] [Abstract][Full Text] [Related]
4. Allergen-directed expression of Fc receptors for IgE (CD23) on human T lymphocytes is modulated by interleukin 4 and interferon-gamma.
Prinz JC; Baur X; Mazur G; Rieber EP
Eur J Immunol; 1990 Jun; 20(6):1259-64. PubMed ID: 2142456
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor.
Galizzi JP; Cabrillat H; Rousset F; Ménétrier C; de Vries JE; Banchereau J
J Immunol; 1988 Sep; 141(6):1982-8. PubMed ID: 2844892
[TBL] [Abstract][Full Text] [Related]
6. Influence of IL-2 and IL-4 on the IgE synthesis and the IgE-binding factor (sCD23) production by human lymphocytes in vitro.
Knöller I; Bujanowski-Weber J; Brings B; König W
Immunology; 1989 Mar; 66(3):368-75. PubMed ID: 2522907
[TBL] [Abstract][Full Text] [Related]
7. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines.
Bonnefoy JY; Defrance T; Peronne C; Menetrier C; Rousset F; Pène J; De Vries JE; Banchereau J
Eur J Immunol; 1988 Jan; 18(1):117-22. PubMed ID: 2831064
[TBL] [Abstract][Full Text] [Related]
8. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production.
Zhang K; Clark EA; Saxon A
J Immunol; 1991 Mar; 146(6):1836-42. PubMed ID: 1706382
[TBL] [Abstract][Full Text] [Related]
9. Possible role of human lymphocyte receptor for IgE (CD23) or its soluble fragments in the in vitro synthesis of human IgE.
Sarfati M; Delespesse G
J Immunol; 1988 Oct; 141(7):2195-9. PubMed ID: 2971721
[TBL] [Abstract][Full Text] [Related]
10. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma.
Pène J; Rousset F; Brière F; Chrétien I; Paliard X; Banchereau J; Spits H; De Vries JE
J Immunol; 1988 Aug; 141(4):1218-24. PubMed ID: 3135324
[TBL] [Abstract][Full Text] [Related]
11. IL-6 augments Fc IgE receptor (Fc epsilon RII/CD23) expression on human monoblastic/monocytic cell lines U937, THP-1, and Mono-Mac-6 but not on blood monocytes. Regulatory effects of IL-4 and IFN-gamma.
Willheim M; Gessl A; Berger R; Schedle A; Luger T; Föster O; Boltz-Nitulescu G
J Immunol; 1991 Sep; 147(6):1837-42. PubMed ID: 1832425
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes.
Wu CY; Sarfati M; Heusser C; Fournier S; Rubio-Trujillo M; Peleman R; Delespesse G
J Clin Invest; 1991 Mar; 87(3):870-7. PubMed ID: 1825666
[TBL] [Abstract][Full Text] [Related]
13. Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity.
Uchibayashi N; Kikutani H; Barsumian EL; Hauptmann R; Schneider FJ; Schwendenwein R; Sommergruber W; Spevak W; Maurer-Fogy I; Suemura M
J Immunol; 1989 Jun; 142(11):3901-8. PubMed ID: 2523938
[TBL] [Abstract][Full Text] [Related]
14. Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis.
Sherr E; Macy E; Kimata H; Gilly M; Saxon A
J Immunol; 1989 Jan; 142(2):481-9. PubMed ID: 2521348
[TBL] [Abstract][Full Text] [Related]
15. Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways.
Gascan H; Gauchat JF; Aversa G; Van Vlasselaer P; de Vries JE
J Immunol; 1991 Jul; 147(1):8-13. PubMed ID: 1711085
[TBL] [Abstract][Full Text] [Related]
16. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
[TBL] [Abstract][Full Text] [Related]
17. Modulation of IL-4-induced human IgE production in vitro by IFN-gamma and IL-5: the role of soluble CD23 (s-CD23).
Pène J; Chrétien I; Rousset F; Brière F; Bonnefoy JY; de Vries JE
J Cell Biochem; 1989 Mar; 39(3):253-64. PubMed ID: 2496134
[TBL] [Abstract][Full Text] [Related]
18. Expression of low-affinity receptor for IgE (Fc epsilon RII, CD23) and IgE-BF (soluble CD23) release by lymphoblastoid B-cell line RPMI-8866 and human peripheral lymphocytes of normal and atopic donors.
Bujanowski-Weber J; Brings B; Knöller I; Pfeil T; König W
Immunology; 1989 Apr; 66(4):505-11. PubMed ID: 2523859
[TBL] [Abstract][Full Text] [Related]
19. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants.
Del Prete G; Maggi E; Parronchi P; Chrétien I; Tiri A; Macchia D; Ricci M; Banchereau J; De Vries J; Romagnani S
J Immunol; 1988 Jun; 140(12):4193-8. PubMed ID: 2967330
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen.
Pène J; Rousset F; Brière F; Chrétien I; Wideman J; Bonnefoy JY; De Vries JE
Eur J Immunol; 1988 Jun; 18(6):929-35. PubMed ID: 3260186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
